Healthcare 150

Healthcare 150

Healthcare insights, information, and actionable tools to stay ahead - in 5 minutes a week.

Archive

The $10.7B Pharma Deal Reshaping European Healthcare

The $10.7B Pharma Deal Reshaping European Healthcare

We’re unpacking the forces slowing healthcare M&A acceleration in 2026, CVC’s €10.7B bet on European pharma, the rise of oral GLP-1 therapies as scalable healthcare infrastructure, and how Europe and Asia are emerging as a new global healthcare capital axis.

Weekly Round UpWeekly Round Up
Biopharma’s Great Reset Meets a Rural Staffing Squeeze

Biopharma’s Great Reset Meets a Rural Staffing Squeeze

We’re diving into the Biopharma reset, the share of new medicine reimbursement by public insurance, CMS scrutiny expansion, and rural healthcare PA cliff.

Research Deep DiveResearch Deep Dive
From Breakout Growth to Capital Discipline: Why Biopharma Returns Are Losing Momentum

From Breakout Growth to Capital Discipline: Why Biopharma Returns Are Losing Momentum

The biotechnology sector has long occupied a unique position within global capital markets.

Weekly Round UpWeekly Round Up
Biotech Is Back. And Healthcare PE Knows It

Biotech Is Back. And Healthcare PE Knows It

From biotech’s M&A momentum to home health consolidation and rising affordability risks, here’s what’s shaping healthcare strategy in 2026.

SurveysSurveys
Home Healthcare

Home Healthcare

How Aging Demographics, AI, and Decentralized Care Are Transforming the Future of Global Healthcare

Weekly Round UpWeekly Round Up
Healthcare’s $1.5T Shift Out of the Hospital

Healthcare’s $1.5T Shift Out of the Hospital

We’re unpacking the rise of home-based healthcare, how mHealth is evolving from wellness apps into core healthcare infrastructure, the growing reimbursement risks tied to workforce compliance, and why healthcare inflation is becoming a permanent global operating challenge.

Home Healthcare

Home Healthcare

How Aging Demographics, AI, and Decentralized Care Are Transforming the Future of Global Healthcare

Weekly Round UpWeekly Round Up
Europe Is Quietly Winning the Clinical Trial Race

Europe Is Quietly Winning the Clinical Trial Race

healthcare’s renewed focus on outbreak containment, private equity’s continued bet on healthcare staffing infrastructure, Europe’s growing advantage in clinical trial density, and the operational race to build faster, more resilient healthcare systems worldwide.

Weekly Round UpWeekly Round Up
CMS Is Tightening RPM Audits — Investors Should Pay Attention

CMS Is Tightening RPM Audits — Investors Should Pay Attention

We unpack the explosive growth of Remote Patient Monitoring (RPM) and the massive opportunity emerging for healthcare investors.

Research Deep DiveResearch Deep Dive
Remote Patient Monitoring: The New Core of Connected Care

Remote Patient Monitoring: The New Core of Connected Care

How real-time data, AI, and policy reform are redefining healthcare delivery across global systems.

Weekly Round UpWeekly Round Up
Where Margins Hold, Germany Repositions, and Esperion’s $1B Exit

Where Margins Hold, Germany Repositions, and Esperion’s $1B Exit

The primary margin protection strategy for the next 12 months, Germany’s biotech evolution, and Experion’s $1B bet on commercial cardio assets.

SurveysSurveys
Healthcare’s Margin Playbook Is Getting More Selective

Healthcare’s Margin Playbook Is Getting More Selective

Margin protection in healthcare used to mean one thing: cut costs faster than revenue slows.

FirstBack
12345678
Next Last